ABBVIE INC. (ABBV)

NYSE

$264.15

$-0.26

(-0.10%)

Regular Market

ABBVIE INC. (ABBV) Live Price Chart

Last updated: ⁦2026-09-18 14:17:40⁩. Prices reflect the latest regular market data. Stock price data is sourced from Massive.

Summary

ABBVIE INC. (ABBV) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NYSE. The stock is currently priced at $264.16, with a market capitalisation of $463.89B and a P/E ratio of 74.17. Over the past 52 weeks, its price has ranged from $190.75 to $267.47. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$463.89B
Open	$263.29
Day's High	$267.47
Day's Low	$33.33
Previous Close	$264.02
Volume	1.28M
Average Volume	6.31M
P/E Ratio	74.17
52-Week High	$267.47
52-Week Low	$190.75
Dividend Yield	2.57%
Earnings Date	--

ABBVIE INC. (ABBV) Stock Price Today

ABBVIE INC. (ABBV) is currently trading at $264.16 as of 2026-09-18 14:00:59, up 0.05% ($0.13) from the previous close of $264.02

During today's regular trading session, ABBV has traded between $33.33 and $267.47, with a trading volume of 1.28M shares. The current price is near the upper end of today's range.

ABBVIE INC. (ABBV) 7-Day Stock Price Change

Over the past seven days, ABBVIE INC. (ABBV) moved from $250.91 to $264.16, representing a gain of 5.28% ($13.24).

The stock traded between $246.77 and $266.07 during the period. The latest price is near the upper end of the 7-day range, indicating strong upward.

The average daily volume was 4.12 million shares, up versus the previous seven-day period, indicating higher trading activity.

ABBV 52-Week Price Position

Position in Range: 95.7%

52W Low$190.75

52W High$267.47

ABBV is currently trading at $264.16, placing it 95.7% of the way from its 52-week low of $190.75 to its 52-week high of $267.47. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is ABBVIE INC. (ABBV)?

AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics, including Botox. The 2024 acquisitions of Cerevel (neuroscience) and ImmunoGen (oncology) help supplement AbbVie's portfolio.

ABBVIE INC. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	57000
Exchange	NYSE
Company Website	https://www.abbvie.com

How to Buy ABBVIE INC. (ABBV) Stock on MEXC

Eligible investors can buy real shares of ABBVIE INC. (ABBV) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licenced broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for ABBV and Place Your Order

Open the RealStocks trading page and search for ABBV. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is ABBVIE INC. (ABBV) share price today?

ABBVIE INC. (ABBV) is currently trading at $ 264.16, up 0.05% ($0.13) from the previous close of $ 264.02. Intraday prices update in real time during regular trading hours.

2.Is ABBV stock going up or down today?

As of 2026-09-18 14:00:59, ABBV is trading at $ 264.16, up 0.05% ($0.13) from its previous close of $ 264.02. The stock has traded between $ 33.33 and $ 267.47 during today’s regular session. Past price movements do not guarantee future results.

3.What is ABBV pre-market price?

As of 2026-09-18 14:00:59, ABBV is trading at $ 263.01 in pre-market trading, down 0.38% ($1.01) from the previous close of $ 264.02. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is ABBV after-hours price?

As of 2026-09-18 14:00:59, ABBV is trading at $ 264.00 in after-hours trading, down 0.01% ($0.02) from the regular-session close of $ 264.02. After-hours prices may differ from the regular session's opening price due to lower liquidity and wider bid-ask spreads.

5.Is ABBV stock trading now?

ABBV trades on the NYSE exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does ABBV sit relative to its 52-week high and low?

Over the past 52 weeks, ABBV has traded between a low of $ 190.75 and a high of $ 267.47. At $ 264.16, the stock is positioned 95.7% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is ABBVIE INC. in?

ABBVIE INC. (ABBV) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is ABBVIE INC.'s market capitalisation and where is it listed?

ABBVIE INC. is listed on the NYSE exchange with a market capitalisation of $ 463.89B. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is ABBV valued in terms of P/E ratio and EPS?

ABBV trades at a P/E ratio of 74.17, based on trailing-twelve-month EPS of $ 3.56. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does ABBVIE INC. pay a dividend?

ABBVIE INC. pays an indicated annual cash dividend of $ 6.79 per share, with a current dividend yield of 2.57% based on the latest share price. Dividend policies are subject to change at the board's discretion.